跳至主要内容
临床试验/NCT00196079
NCT00196079已完成不适用

The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial

Cook Group Incorporated1 个研究点 分布在 1 个国家目标入组 177 人开始时间: 2000年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
177
试验地点
1
主要终点
Angiographic in-stent % diameter at follow-up.

研究概览

简要总结

The ASPECT study is an Asian multicenter, randomized, controlled, triple-blinded study designed to evaluate the ability of the Cook Incorporated Paclitaxel Eluting Supra G Coronary Stent to reduce restenosis in the coronary artery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient must be eligible to undergo planned treatment of a single de novo lesion in a native coronary artery.
  • Patient must be an acceptable candidate for coronary artery bypass surgery.
  • Patient must have given signed informed consent.
  • Patient agrees to return at one month for an office visit to assess cardiovascular status and at 4-6 months for an office visit to assess cardiovascular status and for a diagnostic angiogram.

排除标准

  • Patient is less than 18 years old.
  • Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions.
  • The patient is simultaneously participating in another investigative interventional cardiovascular device or drug study.
  • Patient has known hypersensitivity or contraindication to aspirin, Clopidogrel, or stainless steel, or a sensitivity to contrast dye that.
  • Patient is pregnant.
  • Patient has other medical condition that may cause the patient to be non-compliant with the protocol, confound the results or is associated with limited life expectancy.

结局指标

主要结局

Angiographic in-stent % diameter at follow-up.

次要结局

  • Total lesion revascularization
  • Major adverse events

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验